We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.
- Authors
Ardizzoni, A; Hansen, H; Dombernowsky, P; Gamucci, T; Kaplan, S; Postmus, P; Giaccone, G; Schaefer, B; Wanders, J; Verweij, J
- Abstract
To assess activity and toxicity of topotecan in previously treated small-cell lung cancer (SCLC) patients.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Vol 15, Issue 5, p2090
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1997.15.5.2090